Parkinson’s disease is the second most common incurable neurodegenerative disorder after Alzheimer’s disease.
It is characterised by the accumulation of protein deposits in dopaminergic neurons (in charge of producing dopamine) in the form of amyloid fibres. These aggregates are formed mainly by the alpha-synuclein protein and in a very complex manner, which makes it complicated to identify molecules which could prevent or revert the process and the neurodegeneration associated with it.
A scientific collaboration led by researchers at the Institute of Biotechnology and Biomedicine (IBB) of the Universitat Autònoma de Barcelona has identified a molecule which halts and reverts this neurodegeneration. After analysing over 14,000 molecules, they found the SynuClean-D molecule, which inhibits the aggregation of the alpha-synuclein protein and breaks the already formed amyloid fibres, thus preventing the initiation of the process causing the onset of the neurodegenerative Parkinson’s disease.
Through experiments conducted with the small Caenorhabditis elegans worm, one of the most commonly used animal models in neurodegenerative diseases, researchers were able to verify that by administering it through food, the molecule was capable of notably reducing alpha-synuclein aggregations, preventing the spread of toxic aggregates and therefore avoiding the degeneration of dopaminergic neurons.
“Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative disases such as Parkinson’s in the future”, UAB researcher and coordinator of the study Salvador Ventura points out.
To identify SynuClean-D researchers developed a methodology capable of indentifying the alpha-synuclein aggregation inhibitors among thousands of molecules. Once identified, an in vitro biophysical characterisation was conducted of their inhibiting activity and tests were run to discover their behaviour with human neural cell cultures, before testing it in animal models of the disease (the Caenorhabditis elegans worm). These animals express the alpha-synuclein in the muscle or in dopaminergic neurons. The experiments demonstrated that the administration of the identified inhibitor reduced protein aggregation, improving the mobility of the animal and protecting it from neural degeneration.
The Latest on: Parkinson’s
via Google News
The Latest on: Parkinson’s
- New Clinical Investigation Approved for Treatment of Early-Stage Parkinson’s diseaseon January 17, 2022 at 6:24 pm
Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational New Drug (IND) application for the global multi-center phase-II clinical trial of ...
- Parkinson’s Disease Pipeline Offers Promising New Options for Treatment | DelveInsighton January 17, 2022 at 5:02 pm
DelveInsight’s “Parkinson’s Disease Pipeline Insight” report provides comprehensive insights about 150+ companies and 150+ pipeline drugs in the Parkinson’s Disease pipeline landscapes.Los Angeles, ...
- Exercise Slows Progression, Cognitive Decline in Early Parkinson'son January 17, 2022 at 12:19 pm
The study found moderate-to-vigorous exercise and even ordinary physical activity has a beneficial impact on slowing disease progression and cognitive decline in Parkinson's disease.
- Brandi Parkinson, Hermitage, PAon January 17, 2022 at 9:28 am
In loving memory of Brandi Parkinson of Hermitage, Pennsylvania. She was born September 15, 1972 at Farrell Hospital and was called home to the lord on Friday, January 14, 2022. Brandi was a graduate ...
- If You Feel Stiffness Here, It May Be the First Sign of Parkinson'son January 16, 2022 at 4:02 am
Parkinson's disease (PD) affects one million Americans and 10 million people around the world. A progressive motor disease, PD is known to cause a wide range of symptoms, including tremor, slowness of ...
- Parkinson’s progression may slow with four hours a week of exercise, study sayson January 14, 2022 at 1:44 pm
For people with early-stage Parkinson’s disease, four hours a week of moderate exercise may help slow the progression of the disease. Symptoms of Parkinson’s, which is a movement disorder, generally ...
- Regular Exercise Linked to Slower Deterioration in Parkinson Diseaseon January 14, 2022 at 7:51 am
For patients with early Parkinson disease (PD), average regular overall physical activity levels over time are associated with slower deterioration of postural and ...
- Seahawks' Colby Parkinson: Just five catches in second seasonon January 14, 2022 at 6:12 am
Parkinson re-injured his foot in August and ended up missing the first three games of the season as a result. He rarely played when both Gerald Everett and Will Dissly were healthy, as he averaged ...
- Regular physical activity may help slow Parkinson's diseaseon January 13, 2022 at 8:16 am
A few hours of exercise a week may help slow Parkinson's disease, even if it's just moderate activity such as walking or gardening, a new study suggests.
via Bing News